Filing Details
- Accession Number:
- 0001179110-13-008089
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-05-09 16:15:24
- Reporting Period:
- 2013-05-02
- Filing Date:
- 2013-05-09
- Accepted Time:
- 2013-05-09 16:15:24
- Original Submission Date:
- 2013-05-07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
203077 | St Jude Medical Inc | STJ | Electromedical & Electrotherapeutic Apparatus (3845) | 411276891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1233308 | R Richard Devenuti | One St. Jude Medical Drive St. Paul MN 55117 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-02 | 3,650 | $40.68 | 16,286 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2013-05-02 | 5,600 | $38.45 | 21,886 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-02 | 5,270 | $40.64 | 16,616 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2013-05-02 | 5,600 | $0.00 | 5,600 | $38.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-11-11 | 2013-05-11 | No | 4 | M | Direct |
Footnotes
- These shares are restricted. The restrictions on these shares will lapse on December November 2, 2013.
- The price in Column 4 is a weighted average. The prices actually received ranged from $40.6400 to $40.6412. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- This form has been amended to correctly reflect the number of shares sold and increase the number of shares directly held as a result of the change in shares sold. The remainder of the form has been set forth in its entirety without change.